GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (HKSE:03933) » Definitions » Balance Sheet Cash And Cash Equivalents

United Laboratories International Holdings (HKSE:03933) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


United Laboratories International Holdings Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
Executives
Heren Far East #4 Limited 2201 Interest of corporation controlled by you
Heren Far East Limited 2101 Beneficial owner
Iq Eq Services (hk) Limited 2201 Interest of corporation controlled by you